The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database

Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla, Claus Franz Vogelmeier

Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla, Claus Franz Vogelmeier. The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database. Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study
Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020
Year: 2021



What makes Alpha1-antitrypsin deficiency patients exacerbate: a 5-year cohort
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results.
Source: Virtual Congress 2021 – Treatments for airway diseases
Year: 2021


Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population
Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Year: 2020


Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011

The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database
Source: Eur Respir J 2016; 47: 1162-1169
Year: 2016



Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015


Prevalence of severe asthma – results from a population-based study.
Source: International Congress 2019 – Asthma and the world
Year: 2019


Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report
Source: Eur Respir J 2005; 26: Suppl. 49, 440s
Year: 2005

The incidence of alpha-1-antitrypsin (A1AT) deficiency alleles in Polish population – Results from the ongoing newborn screening
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort
Source: Eur Respir J 2016; 48: 264-268
Year: 2016


Excess economic burden of comorbidities in COPD: a 15-year population-based study
Source: Eur Respir J, 50 (1) 1700393; 10.1183/13993003.00393-2017
Year: 2017



Psychiatric disorders in patients with COPD: a population-based study on prevalence and the relationship with smoking
Source: Eur Respir J 2001; 18: Suppl. 33, 192s
Year: 2001

Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study
Source: Eur Respir J 2015; 45: 269-272
Year: 2015


Diabetic status and the risk of tuberculosis: a nationwide population-based study
Source: Virtual Congress 2020 – Tuberculosis: part 1
Year: 2020

Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019



Type 2 diabetes mellitus risk associated with sarcoidosis: A Swedish population-based cohort study
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020




Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020
Year: 2021



Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Source: Eur Respir J 2016; 48: 1690-1699
Year: 2016